Sort   by:  
 Page size 
UnknownChromatin modification requirements for 15-lipoxygenase-1 transcriptional reactivation in colon cancer cells.
Not available
S-EPMC2581547 | biostudies-literature
UnknownALOX15 as a suppressor of inflammation and cancer: Lost in the link.
Not available
S-EPMC5509529 | biostudies-literature
UnknownCelecoxib Colorectal Bioavailability and Chemopreventive Response in Patients with Familial Adenomatous Polyposis.
Not available
S-EPMC8980107 | biostudies-literature
UnknownTargeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.
Not available
S-EPMC2684551 | biostudies-literature
UnknownOxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity.
Not available
S-EPMC1432095 | biostudies-literature
UnknownPhase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.
Not available
S-EPMC5562357 | biostudies-literature
Unknown15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
Not available
S-EPMC4447220 | biostudies-literature
UnknownGlobal quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool.
Not available
S-EPMC3574220 | biostudies-literature
UnknownUtility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials.
Not available
S-EPMC6276928 | biostudies-literature
UnknownEffects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice.
Not available
S-EPMC3341308 | biostudies-literature
Sort   by:  
 Page size